Actively Recruiting
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
Led by AstraZeneca · Updated on 2026-05-05
300
Participants Needed
66
Research Sites
221 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This survey will be conducted to investigate the status of occurrence of the safety specifications set for "Safety specification" in patients who received Ondexxya Intravenous Injection 200 mg. In addition, this survey will be implemented to understand the followings by collecting safety and effectiveness information under actual use conditions.
CONDITIONS
Official Title
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients treated with this drug to neutralize the anticoagulant effect of a FXa inhibitor (apixaban, rivaroxaban, or edoxaban) at onset of a life-threatening bleeding episode or a unarrestable bleeding episode.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 66 locations
1
Research Site
Aichi, Japan
Withdrawn
2
Research Site
Aichi, Japan
Actively Recruiting
3
Research Site
Akita, Japan
Withdrawn
4
Research Site
Aomori, Japan
Withdrawn
5
Research Site
Chiba, Japan
Withdrawn
6
Research Site
Chiba, Japan
Active, Not Recruiting
7
Research Site
Ehime, Japan
Active, Not Recruiting
8
Research Site
Ehime, Japan
Withdrawn
9
Research Site
Fukui, Japan
Withdrawn
10
Research Site
Fukui, Japan
Active, Not Recruiting
11
Research Site
Fukuoka, Japan
Withdrawn
12
Research Site
Fukuoka, Japan
Active, Not Recruiting
13
Research Site
Fukushima, Japan
Withdrawn
14
Research Site
Gifu, Japan
Withdrawn
15
Research Site
Gifu, Japan
Active, Not Recruiting
16
Research Site
Gunma, Japan
Withdrawn
17
Research Site
Gunma, Japan
Active, Not Recruiting
18
Research Site
Gunma, Japan
Actively Recruiting
19
Research Site
Hiroshima, Japan
Withdrawn
20
Research Site
Hokkaido, Japan
Withdrawn
21
Research Site
Hokkaido, Japan
Active, Not Recruiting
22
Research Site
Hyōgo, Japan
Withdrawn
23
Research Site
Ibaraki, Japan
Withdrawn
24
Research Site
Ishikawa, Japan
Withdrawn
25
Research Site
Kagawa, Japan
Withdrawn
26
Research Site
Kagoshima, Japan
Withdrawn
27
Research Site
Kanagawa, Japan
Withdrawn
28
Research Site
Kanagawa, Japan
Active, Not Recruiting
29
Research Site
Kochi, Japan
Withdrawn
30
Research Site
Kumamoto, Japan
Withdrawn
31
Research Site
Kumamoto, Japan
Active, Not Recruiting
32
Research Site
Kyoto, Japan
Withdrawn
33
Research Site
Mie, Japan
Withdrawn
34
Research Site
Mie, Japan
Active, Not Recruiting
35
Research Site
Miyagi, Japan
Withdrawn
36
Research Site
Miyazaki, Japan
Withdrawn
37
Research Site
Nagano, Japan
Withdrawn
38
Research Site
Nagano, Japan
Active, Not Recruiting
39
Research Site
Nagasaki, Japan
Withdrawn
40
Research Site
Nagasaki, Japan
Actively Recruiting
41
Research Site
Nara, Japan
Withdrawn
42
Research Site
Niigata, Japan
Withdrawn
43
Research Site
Niigata, Japan
Active, Not Recruiting
44
Research Site
Numakunai, Japan
Withdrawn
45
Research Site
Okayama, Japan
Withdrawn
46
Research Site
Okinawa, Japan
Withdrawn
47
Research Site
Osaka, Japan
Withdrawn
48
Research Site
Osaka, Japan
Active, Not Recruiting
49
Research Site
Saga, Japan
Withdrawn
50
Research Site
Saitama, Japan
Withdrawn
51
Research Site
Shiga, Japan
Withdrawn
52
Research Site
Shimane, Japan
Withdrawn
53
Research Site
Shizuoka, Japan
Withdrawn
54
Research Site
Tochigi, Japan
Withdrawn
55
Research Site
Tochigi, Japan
Active, Not Recruiting
56
Research Site
Tokushima, Japan
Withdrawn
57
Research Site
Tokyo, Japan
Withdrawn
58
Research Site
Tokyo, Japan
Active, Not Recruiting
59
Research Site
Tottori, Japan
Active, Not Recruiting
60
Research Site
Toyama, Japan
Withdrawn
61
Research Site
Wakayama, Japan
Withdrawn
62
Research Site
Wakayama, Japan
Active, Not Recruiting
63
Research Site
Yamagata, Japan
Withdrawn
64
Research Site
Yamagata, Japan
Active, Not Recruiting
65
Research Site
Yamaguchi, Japan
Withdrawn
66
Research Site
Yamanashi, Japan
Withdrawn
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here